U.S. Physical Therapy, Inc. (NYSE:USPH) COO Graham D. Reeve Sells 1,792 Shares

Key Points

• U.S. Physical Therapy COO Graham D. Reeve sold 1,792 shares at an average price of $86.57, reducing his holdings by 7.45% to a total of 22,246 shares worth approximately $1.93 million.
• The company reported a net margin of 5.05% and revenue of $197.34 million for the last quarter, exceeding estimates and showing an 18.0% increase compared to the previous year.
• U.S. Physical Therapy declared a quarterly dividend of $0.45 per share, with an annual yield of 2.1%, to be paid on September 12th.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) COO Graham D. Reeve sold 1,792 shares of the company's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $86.57, for a total value of $155,133.44. Following the completion of the transaction, the chief operating officer directly owned 22,246 shares of the company's stock, valued at approximately $1,925,836.22. This trade represents a 7.45% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

U.S. Physical Therapy Price Performance

USPH stock traded down $0.26 during midday trading on Friday, reaching $85.72. 218,542 shares of the company's stock traded hands, compared to its average volume of 190,340. The company has a 50-day simple moving average of $77.56 and a two-hundred day simple moving average of $76.95. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The company has a market cap of $1.30 billion, a price-to-earnings ratio of 37.43, a PEG ratio of 4.38 and a beta of 1.45. The company has a quick ratio of 1.17, a current ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. The firm had revenue of $197.34 million during the quarter, compared to analysts' expectations of $190.24 million. During the same period last year, the firm posted $0.73 EPS. The business's revenue was up 18.0% on a year-over-year basis. On average, analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 78.60%.

Institutional Investors Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently bought and sold shares of the business. Copeland Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 8.9% in the 2nd quarter. Copeland Capital Management LLC now owns 888,735 shares of the company's stock worth $69,499,000 after purchasing an additional 72,463 shares during the last quarter. Southernsun Asset Management LLC boosted its position in shares of U.S. Physical Therapy by 4.5% in the 4th quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company's stock worth $50,725,000 after purchasing an additional 24,698 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of U.S. Physical Therapy by 1.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock worth $37,818,000 after purchasing an additional 7,890 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company's stock worth $27,602,000 after purchasing an additional 4,306 shares during the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in shares of U.S. Physical Therapy by 9.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company's stock worth $27,070,000 after purchasing an additional 29,671 shares during the last quarter.

Analyst Ratings Changes

Several equities analysts have commented on the company. JMP Securities reaffirmed a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Barrington Research increased their target price on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Thursday, May 8th. Finally, Zacks Research raised U.S. Physical Therapy to a "hold" rating in a report on Friday, August 8th. Three investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.